✦ LIBER ✦

Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis

✍ Scribed by Uchida, A.; Maida, E.M.; Lenzhofer, R.; Micksche, M.

Book ID: 122763738
Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 622 KB
Volume: 160
Category: Article
ISSN: 0171-2985
DOI: 10.1016/S0171-2985(82)80003-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natural killer cells activity in patient

Natural killer cells activity in patients with multiple sclerosis given α interferon

✍ George P. A. Rice; Paolo Casali; Thomas C. Merigan; Michael B. A. Oldstone 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

Natural killer cell activity in multiple

Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-α2

✍ Robert L. Hirsch; Kenneth P. Johnson 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 684 KB

Natural killer cell number and activity

Natural killer cell number and activity in multiple sclerosis

✍ Zoran Vranesˇ; Zdravko Poljaković; Matko Marusˇić 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 503 KB

Interferon production and natural killer

Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients

✍ Greta Vervliet; Hendrik Claeys; Hilde van Haver; Herwig Carton; Carl Vermylen; E 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 791 KB

Natural killer (NK) cells in chronic pro

Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferon

✍ Lorne F. Kastrukoff; Norma G. Morgan; Terry M. Aziz; Daniel Zecchini; Jonathan B 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 629 KB

Lymphokine-activated killer cell and nat

Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis

✍ Thomas V. Kantor; Theresa L. Whiteside; Diana Friberg; Robert B. Buckingham; Tho 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 2 views

Objective. To determine the ability of T lymphocytes and natural killer (NK) cells from patients with systemic sclerosis (SSc) to respond to cytokines and to generate immune effector cells. Methods. The numbers and percentages of peripheral blood T and NK cells were examined by 2-color flow cytometr